Synta Pharmaceuticals Corp. Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Lexington MA United States (2000)
Status: Acquired by Madrigal Pharmaceuticals (2016)

Organization Overview

First Clinical Trial
2003
NCT00088114
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree